Our experts led the project as both Project Manager and Cost Manager, working closely with GSTT, CCTech and Scitech to navigate the technical and logistical challenges of building within a live clinical environment. The team oversaw programme delivery, risk management and cost control, ensuring the project remained aligned with strategic objectives and regulatory requirements.

Beyond core delivery, we provided procurement advice for professional services and main works, managed RIBA Stage 2 to 4 designs and ran two competitive open-market tenders for the design team and GMP lab contractor. To maintain momentum and avoid costly demobilisation, we proactively advanced works into the Pre-Construction Services Agreement (PCSA) phase.

Our team’s leadership ensured the facility met GMP guidelines, MHRA licensing requirements and GSTT’s internal policies. The team secured planning permission for external louvres, expanded cryo-storage capacity and coordinated multi-department relocations, all while managing multiple contract awards and securing Trust board approvals.

The result is a facility that supports advanced therapy manufacturing in line with the highest technical and regulatory standards. Our approach reflects a deep understanding of healthcare infrastructure and a commitment to delivering future-ready environments that support clinical innovation.

The successful delivery of this £7.5 million GMP facility positions Guy’s Hospital at the forefront of cell therapy development. It demonstrates GSTT’s commitment to investing in specialist infrastructure and highlights our ability to manage complex healthcare projects with precision and agility.